Coronary atheroma burden predicts flow reserve in women with ischemia and nonobstructive coronary artery disease

C Pacheco1, A AlBadri2, R D Anderson3

  • 1Hôpital Pierre-Boucher, Centre Hospitalier de l'Université de Montréal, Université de Montreal, QC, Canada.

Insights

Epicardial coronary anatomy measures correlate with coronary flow reserve in women with ischemia symptoms. Atherosclerotic findings may contribute to or result from coronary microvascular dysfunction (CMD).

Area of Science:

  • Cardiology
  • Vascular Biology
  • Diagnostic Imaging

Background:

  • Coronary microvascular dysfunction (CMD) is common in women with ischemia symptoms and non-obstructive coronary artery disease.
  • Reduced coronary flow reserve (CFR) and compensatory coronary remodeling are characteristic of CMD.
  • Angiographic measurements of epicardial coronary anatomy (AMCA) may offer insights into the relationship between CFR and atherosclerosis.

Purpose of the Study:

  • To investigate the relationship between AMCA and CFR in women evaluated for CMD.
  • To explore how epicardial coronary anatomy influences coronary blood flow and microvascular function.

Main Methods:

  • Utilized data from the Women's Ischemia Syndrome Evaluation CVD Continuation study.
  • Assessed CFR using clinically indicated coronary function testing.
  • Quantified AMCA, including atheroma burden (AB), percent diameter stenosis (PDS), and reference diameter Z score (RDZ) for epicardial segments.

Main Results:

  • Fifty-one women (mean age 55.8 years) with a mean CFR of 3.0 were analyzed.
  • Both average and maximal AB and PDS showed negative correlations with CFR (p<0.05).
  • Average RDZ was directly related to CFR (r=0.37, p=0.01), and PDS independently predicted lower CFR.

Conclusions:

  • Epicardial coronary atheroma burden, size, and tapering are associated with CFR.
  • These atherosclerotic anatomical findings may contribute to or be a consequence of CMD.
  • Further research is needed to evaluate these measures as potential therapeutic targets for CMD.
Abstract